Sun Pharmaceutical Industries Limited — Dividend/Bonus, 16-01-2025: Record Date

Sun Pharmaceutical Industries Limited has announced a board meeting on January 31, 2025, to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2024, and to declare an interim dividend for the financial year 2024-25. If the dividend is declared, it will be payable to equity shareholders whose names are recorded as of January 31, 2025, which serves as the record date. The trading window is closed from January 1, 2025, until February 2, 2025, to facilitate these proceedings.